# Role of Transcranial Doppler and Magnetic Resonance Angiography for Future Management of Sickle Cell Anemia CNS.

> **NCT06498726** · — · NOT_YET_RECRUITING · sponsor: **Eman Abdul-Hai** · enrollment: 18 (estimated)

## Conditions studied

- Blood Disease
- Brain Injuries

## Interventions

- **DEVICE:** transcranial doppler

## Key facts

- **NCT ID:** NCT06498726
- **Lead sponsor:** Eman Abdul-Hai
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-09-01
- **Primary completion:** 2025-09-01
- **Final completion:** 2025-10-01
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2024-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06498726

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06498726, "Role of Transcranial Doppler and Magnetic Resonance Angiography for Future Management of Sickle Cell Anemia CNS.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06498726. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*